Article
Moderna: Interim data show 94.5% efficacy for COVID-19 vaccine, will seek FDA EUA
November 16, 2020
The first interim results of the phase 3 COVE trial included 95 participants with confirmed COVID-19.
News
Empagliflozin favorably reshaped left ventricles in HFrEF patients
November 15, 2020
Results from two separate randomized studies showed empagliflozin treatment of patients with HFrEF produced significant heart remodeling.
News
Intravenous iron reduces HF readmissions: AFFIRM-AHF
November 14, 2020
The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts say.
News
GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit
November 13, 2020
Omecamtiv mecarbil safely met its primary efficacy endpoint in patients with heart failure with reduced ejection fraction in GALACTIC-HF, but with a modest effect.
News
Escalate HIV adherence strategies amid COVID-19
November 13, 2020
Virtual care is not meeting the needs of people with HIV who struggled with viral suppression even before the COVID-19 pandemic.
News
Situation ‘dire’ as COVID spike in West, Midwest worsens, experts say
November 13, 2020
“I think the situation in 2 to 4 weeks is going to be grim,” said Dr. Andrew Pavia.
News
Nearly one in five develop mental illness following COVID-19
November 13, 2020
The study also showed that having a psychiatric disorder independently increases the risk of getting COVID-19.
News
New reports guide return to play in athletes with COVID-19
November 13, 2020
Researchers found a high prevalence of pericardial involvement in college-student athletes who have recovered from COVID-19.
News
AMA creates COVID-19 CPT codes for Pfizer, Moderna vaccines
November 13, 2020
AMA plans to introduce more vaccine-specific CPT codes as more vaccine candidates approach FDA review.
News
Monthly needlestick rates suggest a steep learning curve
November 12, 2020
Nonsurgical specialists should receive more training in injury prevention.